LeonaBio LONA
NASDAQ LONA
$3.82 -0.20 (-5.10%)
As of: Nov 11, 2026 · 11:44 AM EST

LeonaBio (LONA) Preferred Stock Liabilities (2019 - 2020)

Updated

LeonaBio (LONA) posted Preferred Stock Liabilities of $92.54 million for Q2 2020.

Analysis

LeonaBio (LONA) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, LeonaBio's Preferred Stock Liabilities came in at $17.05 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 LeonaBio 95.38 Mn -136.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 17.05 Mn
Sep 30, 2020 17.05 Mn
Jun 30, 2020 92.54 Mn
Dec 31, 2019 17.05 Mn
Sep 30, 2019 17.05 Mn
API Access

LeonaBio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=LONA&period=max&api_key=YOUR_API_KEY